Acute Study on Muscle Soreness, Damage, and Performance

Performance Enhancing Product Use Clinical Trial

Official title: A Randomized, Double-blind, Placebo Controlled, Single-center Study to Determine the Effects of Pre-workout and Recovery Formulations on Soreness, Performance, Tolerance and Safety Outcomes in Healthy Adults Undergoing Training Program

Status Completed

Clinical Trial Summary

The acute study will evaluate pre- and post-exercise ingestion of a multi-ingredient supplement in a randomized, double-blind, placebo-controlled, crossover design. Participants will complete one enrollment visit, in which they will sign a consent form and complete a health history questionnaire. Participants will complete two interventions, with three visits each (6 visits total), in which a treatment beverage (pre/post supplement, or non-caloric placebo) will be consumed within 30 minutes prior to exercise and within 15 minutes post-exercise, in random order. Total time from enrollment to completion will be at least 14 days. Testing visits will be separated by a minimum of 7 days of rest to allow for recovery and washout, based on a half-life of ≤8 hours for all ingredients present in the supplement.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Damage Muscle
• Myalgia
• Performance Enhancing Product Use
• Soreness, Muscle

• NCT number: NCT04230226
• Study type: Interventional
• Source: Pharmanex
• Status: Completed
• Phase: N/A
• Start date: January 21, 2020
• Completion date: September 16, 2020